The purpose of this study was to investigate perioperative complications in patients receiving hepatic arterial infusion chemotherapy (HAI) prior to hepatectomy and hepatic toxicity associated with HAI. A retrospective review of 15 patients undergoing hepatectomy for colorectal liver metastases initially unresectable downstaged by HAI to the point that operation was performed. HAI consists of 5FU alone in 6 patients, 5FU with cisplatin in 7 patients, and 5FU with mitomycin C in 2 patients. We classified the patients into 2 groups by the total amount of 5FU (Group A > 15.0g/m
2, B≤15.0g/m
2). We investigated perioperative parameters and pathological findings of hepatic toxicity in the non-neoplastic liver in both groups. The average age of patients was 62.5 years old (group A = 8, group B = 7). There were significant differences in the amount of 5FU and the frequency of HAI between both groups (P < 0.05). However no significant differences were seen in other parameters of HAI, patients back ground, tumor parameters, and operative and perioperative parameters between both groups. Regarding pathological findings of the non-neoplastic liver, steatohepatitis more than Kliner score 4 was all in the group A (3 patients), and there were no sinusoidal dilatations of more than grade 2 in both groups. Pathological findings indicated 3 patients with hepatic injury, all in group A (37.5%). We conclude that there are some risks of pathological hepatic injury with steatohepatitis after HAI when the total amount of 5FU is more than 15g/m
2. However HAI prior to hepatectomy is not associated with an increase of perioperative mortality and morbidity.
View full abstract